Trial intelligence / Profile preview

Maintenance Effect of Clobex Shampoo in Scalp Psoriasis

NCT00400725Phase 3Completed

Sponsor
Galderma
Start
Sep 2006
Primary completion
Aug 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of clobetasol in psoriasis (3 arms), sponsored by Galderma. Primary endpoint: Time to First Relapse at 24 weeks. Started Sep 2006; status: completed.

02

Drugs

clobetasol
03

Conditions

psoriasis

Beyond the preview

Go deeper on NCT00400725.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00400725.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call